FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Sep 26, 2019
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on September 26, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f1e211bd-1f9f-49c3-9044-8a92286730e4
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1102938
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.105(a)Identification of containers, lines, equipment
- 21 CFR 211.84(d)(6)Objectionable microbiological contamination
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fenwal International, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | San Juan District Office | Blood and Blood Products |
| September 18, 2024 | VAI | San Juan District Office | Blood and Blood Products |
| September 24, 2022 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fenwal International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.